Last reviewed · How we verify

NCT03368755

IUGR, Respiratory Muscle Function, and Exercise Capacity in Childhood

Status unknown NA Last updated 28 April 2021
What this trial tests

NA trial testing Cardiopulmonary Exercise Testing in Intrauterine Growth Restriction in 150 participants. Status unknown.

Timeline
8 January 2018
Primary endpoint
31 December 2021
30 January 2022

Quick facts

Lead sponsorUniversity of Patras
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingdouble
Primary purposediagnostic
Enrollment150
Start date8 January 2018
Primary completion31 December 2021
Estimated completion30 January 2022
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

University of Patras

Who can join

Adults 7 to 10, any sex, with Intrauterine Growth Restriction or Cardiopulmonary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study hypothesis is that intrauterine growth restriction (IUGR) may have long-term effects on respiratory muscle (RM) function, thus leading to reduced exercise capacity later in life. The objective is to investigate the above hypothesis by comparing RM function and cardiopulmonary exercise testing (CPET) parameters between school-aged children exposed to IUGR and healthy controls.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Cardiopulmonary Exercise Testing

Trials testing the same drug.

Other recruiting trials for Intrauterine Growth Restriction

Currently open trials in the same condition.

Other University of Patras trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03368755.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing